The landscape of diabetes care is changing with the emergence of skin-applied GLP-1 therapy. These convenient delivery systems offer a likely simpler alternative to needle administrations for individuals managing diabetes mellitus type 2 . They deliver glucagon-like peptide-1 directly through the